Literature DB >> 7399692

Natural and immune cytolysis of canine distemper virus-infected target cells.

W R Shek, R D Schultz, M J Appel.   

Abstract

Natural and immune cytolysis of canine distemper virus (CDV)-infected target cells in vitro is described. Lymphocytes expressing natural cytotoxicity were found in specific-pathogen-free beagle dogs and in beagle-coonhound crosses before vaccination with CDV and indefinitely after vaccination, when the ephemeral immune lymphocyte-mediated cytotoxicity (ILMC) had declined. In contrast to the natural lymphocyte-mediated cytotoxicity, the ILMC was genetically restricted, could not be blocked by CDV-specific antibody, and was effective against measles virus-infected as well as CDV-infectd target cells. Lymphocyte populations were depleted of Fc receptor and surface immunoglobulin-bearing cells by rosetting techniques and tested in comparison. An antibody-dependent cell-mediated cytotoxicity was demostrated against CDV-infected target cells that were preincubated with CDV antibody when Fc receptor-bearing lymphocytes were not removed. The ILMC was measurable for approximately 10 days beginning at 6 days post-vaccination. In contrast, CDV antibody measured by virus neutralization and humoral cytotoxicity was detectable by 6 days postvaccination and persisted at peak levels for at least 5 months.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399692      PMCID: PMC551011          DOI: 10.1128/iai.28.3.724-734.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  A 51 Cr microassay technique for cell-mediated immunity to viruses.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

3.  Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.

Authors:  R Labowskie; R Edelman; R Rustigian; J A Bellanti
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

Review 4.  Relationships among measles, canine distemper and rinderpest viruses.

Authors:  D T Imagawa
Journal:  Prog Med Virol       Date:  1968

5.  Lymphocyte typing in allografted beagles.

Authors:  N Mollen; F D Cannon; J W Ferrebee; D St John
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

6.  Pathogenesis of canine distemper.

Authors:  M J Appel
Journal:  Am J Vet Res       Date:  1969-07       Impact factor: 1.156

7.  A microneutralization test for canine distemper virus.

Authors:  M Appel; D S Robson
Journal:  Am J Vet Res       Date:  1973-11       Impact factor: 1.156

8.  An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.

Authors:  T Andersson; V Stejskal; B Harfast
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Histocompatibility studies in a closely bred colony of dogs. 3. Genetic definition of the DL-A system of canine histocompatibility, with particular reference to the comparative immunogenicity of the major transplantable organs.

Authors:  J Dausset; F T Rapaport; F D Cannon; J W Ferrebee
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

10.  Relationship between measles and canine distemper viruses determined by delayed type hypersensitivity reactions in dogs.

Authors:  A L Brown; R E McCarthy
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

View more
  9 in total

Review 1.  Natural killer (NK) cells in domestic animals: phenotype, target cell specificity and cytokine regulation.

Authors:  D L Evans; L Jaso-Friedmann
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

2.  Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus.

Authors:  M J Appel; W R Shek; B A Summers
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

3.  Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection.

Authors:  M Vandevelde; F Kristensen; B Kristensen; A J Steck; U Kihm
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes.

Authors:  M J Appel; S G Mendelson; W W Hall
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

5.  Protection against canine distemper virus in dogs after immunization with isolated fusion protein.

Authors:  E Norrby; G Utter; C Orvell; M J Appel
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper.

Authors:  M J Appel; W R Shek; H Shesberadaran; E Norrby
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.

Authors:  Peter Ross; Paige S Nemec; Alexander Kapatos; Keith R Miller; Jennifer C Holmes; Steven E Suter; Adam S Buntzman; Erik J Soderblom; Edward J Collins; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2018-02-02       Impact factor: 2.046

8.  Primary demyelination in experimental canine distemper virus induced encephalomyelitis in gnotobiotic dogs. Sequential immunologic and morphologic findings.

Authors:  R J Higgins; S G Krakowka; A E Metzler; A Koestner
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 9.  Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy.

Authors:  Alicia A Gingrich; Jaime F Modiano; Robert J Canter
Journal:  J Clin Med       Date:  2019-10-27       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.